“Exploiting sex differences in glioblastoma for next generation of immunotherapies”

Justin D. Lathia
  • Justin D. Lathia, Ph.D., Melvin H. Burkhardt Endowed Chair for Neuro-Oncology Clinical Research, Lerner Research Institute, Cleveland Clinic; Department of Molecular Medicine, Case Western Reserve University School of Medicine

  • Thurs. May 26, 2022

  • 3:50 – 4:15 p.m.

  • Washington Room, Hotel Roanoke

Abstract: Sex differences are present the human population and impact a variety of homeostatic and disease processes. I will discuss the extent of sex differences in glioblastoma, the most common primary malignant brain tumor, and how this can be leverages for next-generation immunotherapies. In particular, I will focus on how sex differences in immune response reveal new targets for future therapeutic development efforts.